“Modifiable Hyperkalemia with Timely Recognition”- Beta Blocker (Metoprolol succinate) induced
نویسندگان
چکیده
This case report describes the very rarest possibility of drug induced hyperkalemia with beta blockers. In literature search only 2 cases were reported as metoprolol succinate in diabetes patients without renal insufficiency. As per FDA reports 0.5 % have by [1]. Patient is diabetic and hypertensive. And she on oral hypoglycemic agents, premixed insulin blockers along calcium channel blocker. The potassium value was ranging from 6 to 6.7 mmol/l. Evaluated detail no other abnormalities noted laboratory investigations. Once offending withdrawn reaches normal range short period.
منابع مشابه
Metoprolol succinate therapy associated with erythema multiforme.
Metoprolol succinate is a widely used medication for the management of hypertension, heart failure, and angina. We report the case of a 36-year-old woman who developed erythema multiforme after administration of a low dose of this drug. She also presented with pruritic burning pain throughout her body accompanied by chills. While erythema multiforme has been reported with carvedilol, this is th...
متن کاملEffect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy
Aims: β-blockers are underused in Chinese patients with coronary heart disease. The prescribed dose is often low. The aim of this study was to investigate the effect of metoprolol succinate doses of 95 mg and 190 mg on heart rate (HR) control, as well as drug tolerance, in Chinese patients with stable angina, low-dose β-blocker use and unsatisfactory HR control. Methods: This was a multicenter,...
متن کاملSimultaneous Estimation of Metoprolol Succinate and Olmesartan
A simple, precise, specific and accurate reverse phase HPLC method has been developed for the simultaneous determination of Metoprolol succinate (METO) and Olmesartan medoxomil (OLME) in tablet dosage form. The chromatographic separation was achieved on inertsil ODS 3V (250 mm×4.6 mm, 5 μm) column using PDA detector. The mobile phase consisting of Buffer (2 ml O-phosphoric acid in 2000 ml milli...
متن کاملMetoprolol succinate extended release/hydrochlorothiazide combination tablets
Lowering elevated blood pressure (BP) with drug therapy reduces the risk for catastrophic fatal and nonfatal cardiovascular events such as stroke and myocardial infarction. Given the heterogeneity of hypertension as a disease, the marked variability in an individual patient's BP response, and low response rates with monotherapy, expert groups such as the Joint National Committee (JNC) emphasize...
متن کاملNebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1-adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating, vasodilatory effect that is unique among beta-blockers currently available to clinicians (nebivolol is approved in Europe and is currently under review in the US). A NO-potentiating agent such as nebivolol may have an import...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Asian journal of research in medical and pharmaceutical sciences
سال: 2022
ISSN: ['2457-0745']
DOI: https://doi.org/10.9734/ajrimps/2022/v11i330190